Global Automated Immunoassay Analyzers Market Size To Exceed USD 91.16 Billion by 2035| CAGR of 14.11%
Category: HealthcareAccording to a research report published by Spherical Insights & Consulting, The Global Automated Immunoassay Analyzers Market Size is Expected To Grow from USD 21.35 Billion in 2024 to USD 91.16 Billion by 2035, at a CAGR of 14.11% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Automated Immunoassay Analyzers Market Size, Share, and COVID-19 Impact Analysis, By Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, and Radioimmunoassay), By Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, and Allergy Testing), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/automated-immunoassay-analyzers-market
An automated immunoassay analyzer is a piece of equipment used in laboratories to perform immunoassays, which are tests that use the interaction between antigens and antibodies to determine the presence or amount of particular compounds in biological samples. Recent developments in automation and the use of cutting edge technologies have resulted in the launch of novel products. Such products are increasingly being used by numerous biotechnology and pharmaceutical businesses for a variety of objectives, including drug development and allergy testing. A wider range of clinical applications for immunoassay analyzers, new product introductions, and the rising incidence of infectious diseases are further factors that are expected to accelerate the rate of product adoption. Additionally, the aforementioned elements are expected to work together to propel the expansion of the automated immunoassay analyzer business. The rise in infectious illness prevalence is one of the key factors propelling the market expansion for automated immunoassay analyzers. Infectious disease identification at an early stage lowers the risk of serious bodily harm. Therefore, a key driver of market expansion is anticipated to be the quick and accurate screening of illnesses like hepatitis, influenza, sexually transmitted diseases, and many others. However, the automated immunoassay analyzer’s high capital and operational costs are likely to restrict market expansion.
The chemiluminescence segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product, the automated immunoassay analyzer market is divided into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and radioimmunoassay. Among these, the chemiluminescence segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The segment's development is stimulated by the high sensitivity and accuracy of the diagnosis employing low analyte concentration. By identifying hundreds of analytes every hour, these immunoassay analyzers enhance work competency. Customers will like these products due to the chemiluminescence immunoassay's greater receptiveness and dependability.
The infectious diseases segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the automated immunoassay analyzer market is divided into infectious diseases, endocrinology, drug monitoring, chronic diseases, and allergy testing. Among these, the infectious diseases segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment's increase is prompted as it including bacteria, viruses, and parasites, which are the source of infectious diseases, which are extremely contagious. The industry's expansion will be fueled by the increased use of cutting edge molecular techniques as well as government and nonprofit organizations efforts to lessen the burden of infectious diseases, particularly in developing and impoverished areas.
North America is expected to hold the majority share of the global Automated Immunoassay Analyzers market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global automated immunoassay analyzer market during the forecast period. The automated immunoassay analyzer market is encouraged by the strategic presence of important manufacturers. The market will be driven primarily by the high rate of technological adoption in the United States and the growing need for clinically effective immunoassay analyzers during the projected period. More than 85 percent of the regional revenue share in 2023 came from the U.S. market for automated immunoassay analyzers. Positive government regulations and the quick use of automated technology in diagnostic labs ought to support company expansion.
Asia Pacific is anticipated to grow at the fastest pace in the global automated immunoassay analyzer market during the forecast period. The automated immunoassay analyzer market in the Asia Pacific is bolstered by China's global market for automated immunoassay analyzers, which is expanding, with a large patient base available for diagnostic testing and better healthcare infrastructure. Furthermore, in the upcoming years, the arrival of top manufacturers in this area should present encouraging prospects for regional expansion.
Major vendors in the global automated immunoassay analyzer market are Abbott Laboratories, Arlington Scientific, Inc., Becton Dickinson and Company, Bio Rad Laboratories, Inc., Biobase Biodust, Co., Ltd., bioMerieux SA, Carolina Liquid Chemistries Corp., Charles River Laboratories, Chengdu Vacure Biotechnology Co., Ltd., Danaher Corporation, F. Hoffmann La Roche AG, Getein Biotech, Inc., Hipro Biotechnology Co., Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
In September 2021, Thermo Fisher Scientific launched its fully automated analyzers specifically designed for enzyme assay applications. The new analyzer systems combine hardware and new custom designed software to provide fully automated incubation settings, precise measurement calculations, and reagent additions. This development is playing a key role in expanding the company's product portfolio and business growth.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the automated immunoassay analyzer market based on the following segments:
Global Automated Immunoassay Analyzers Market, By Product
- Immunofluorescence
- Chemiluminescence
- Enzyme Linked Fluorescent System
- Radioimmunoassay
Global Automated Immunoassay Analyzers Market, By Application
- Infectious Diseases
- Endocrinology
- Drug Monitoring
- Chronic Diseases
- Allergy Testing
Global Automated Immunoassay Analyzers Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?